PARAMUS, N.J., Aug. 2, 2010 (GLOBE NEWSWIRE) -- Inergetics, Inc. (OTCBB:NRTI), a leader in targeted product development for the Clinical Nutrition and Sports Supplement Markets, today announced that the Company has received a $112,500 purchase order for Resurgex Select™ from New Marketlink Pharmaceutical Corporation "New Marketlink."
The purchase order will only cover the first three months of projected sales of Resurgex Select™ under the Distribution Agreement between Inergetics (formerly Millennium Biotechnologies, Inc.) and New Marketlink, a leading distributor of pharmaceutical and healthcare products in the Philippines. New Marketlink plans to initiate a sales campaign for Resurgex Select™ following the recent Certificate of Product Registration (CPR) issued by the FDA Philippines granting permission to market the product as a nutritional supplement for cancer patients and other immune-compromised individuals throughout the country.
"This initial purchase order from New Marketlink marks the start of their distributor funded sales effort to market and sell Resurgex as a nutritional supplement for cancer patients throughout various countries in Asia and will be the first of many to come from this region of the world," stated Chairman and CEO of Inergetics Inc. Mark Mirken.
"We believe that this is the beginning of a mutually profitable relationship that will begin generating significant revenue in 2011 as New Marketlink gains further market penetration in the Philippines which would then stimulate the launch of our products in other ASEAN countries," continued Mirken.
To learn more about Inergetics, visit www.inergetics.com.
About Inergetics, Inc.
Inergetics, Inc. is a leading developer of nutritional supplements for the Clinical Health and Sports Supplement markets. The Company has established a line of Resurgex products consisting of proprietary nutritional formulas that are used by a wide range of clinical patients and consumers. Resurgex™ products provide comprehensive nutritional support for actively treated cancer patients as well as those in post-treatment care and elderly members of the assisted living community. Inergetics has also developed Surgex™ sports nutrition formula to meet the nutritional needs of professional, Olympic, and amateur elite athletes that experience post-workout symptoms such as fatigue, loss of lean muscle, oxidative stress, and reduced immune function.
Resurgex Essential™ and Resurgex Essential Plus™ are comprehensive, calorically dense formulas that meet and exceed the nutritional requirements of the assisted living community.
Safe Harbor Statement
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of1934. All statements, other than statements of historical fact, including, without limitation, those with respect to the objectives, plans and strategies of the Company and SPI set forth herein and those preceded by or that include the words ``believes,'' ``expects,'' ``given,'' ``targets,'' ``intends,'' ``anticipates, "plans,'' ``projects,'' ``forecasts'' or similar expressions, are "forward-looking statements". Although the Company's management believes that such forward-looking statements are reasonable, it cannot guarantee that such expectations are, or will be, correct. These forward-looking statements involve a number of risks and uncertainties, which could cause the Company's future results to differ materially from those anticipated. The Company assumes no obligation to update any of the information contained or referenced in this press release.